These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36660549)

  • 1. A Case of Congenital Hypotonia and Developmental Delay in an Individual with a
    Makarova E; Legro NR; Aliu E
    Case Rep Genet; 2023; 2023():1581876. PubMed ID: 36660549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel variant in the HX repeat motif of ATN1 in a Chinese patient with CHEDDA syndrome and literature review.
    Luo S; Hu Y; Xiong P; Tan L; Zhao P; Huang Y; Xiao C; Zhu H; He X
    Mol Genet Genomic Med; 2022 Dec; 10(12):e2068. PubMed ID: 36251950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome.
    Palmer EE; Hong S; Al Zahrani F; Hashem MO; Aleisa FA; Ahmed HMJ; Kandula T; Macintosh R; Minoche AE; Puttick C; Gayevskiy V; Drew AP; Cowley MJ; Dinger M; Rosenfeld JA; Xiao R; Cho MT; Yakubu SF; Henderson LB; Guillen Sacoto MJ; Begtrup A; Hamad M; Shinawi M; Andrews MV; Jones MC; Lindstrom K; Bristol RE; Kayani S; Snyder M; Villanueva MM; Schteinschnaider A; Faivre L; Thauvin C; Vitobello A; Roscioli T; Kirk EP; Bye A; Merzaban J; Jaremko Ł; Jaremko M; Sachdev RK; Alkuraya FS; Arold ST
    Am J Hum Genet; 2019 Mar; 104(3):542-552. PubMed ID: 30827498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum.
    Palmer EE; Whitton C; Hashem MO; Clark RD; Ramanathan S; Starr LJ; Velasco D; De Dios JK; Singh E; Cormier-Daire V; Chopra M; Rodan LH; Nellaker C; Lakhani S; Mallack EJ; Panzer K; Sidhu A; Wentzensen IM; Lacombe D; Michaud V; Alkuraya FS
    Clin Genet; 2021 Oct; 100(4):468-477. PubMed ID: 34212383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATN1-related infantile developmental and epileptic encephalopathy responding to Ketogenic diet.
    Xie Y; Su T; Liu Y; Xu S
    Seizure; 2024 Apr; 117():1-5. PubMed ID: 38262122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHEDDA syndrome: a case report and review of the literature for this newly described entity.
    Hui J; Kandemirli SG; Sato TS
    Radiol Case Rep; 2020 Sep; 15(9):1446-1449. PubMed ID: 32642015
    [No Abstract]   [Full Text] [Related]  

  • 7. CAG repeat-binding small molecule improves motor coordination impairment in a mouse model of Dentatorubral-pallidoluysian atrophy.
    Hasuike Y; Tanaka H; Gall-Duncan T; Mehkary M; Nakatani K; Pearson CE; Tsuji S; Mochizuki H; Nakamori M
    Neurobiol Dis; 2022 Feb; 163():105604. PubMed ID: 34968706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
    Suzuki Y; Jin C; Yazawa I
    Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of perampanel for controlling seizures and improving neurological dysfunction in a patient with dentatorubral-pallidoluysian atrophy (DRPLA).
    Shiraishi H; Egawa K; Ito T; Kawano O; Asahina N; Kohsaka S
    Epilepsy Behav Case Rep; 2017; 8():44-46. PubMed ID: 28856097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.
    Suzuki Y; Yazawa I
    Int J Clin Exp Pathol; 2011 Apr; 4(4):378-84. PubMed ID: 21577324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.
    Suzuki Y; Nakayama K; Hashimoto N; Yazawa I
    FEBS J; 2010 Dec; 277(23):4873-87. PubMed ID: 20977674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel de novo KDM5C variant in a female with global developmental delay and ataxia: a case report.
    Lippa NC; Barua S; Aggarwal V; Pereira E; Bain JM
    BMC Neurol; 2021 Sep; 21(1):358. PubMed ID: 34530748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
    Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
    Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A
    Lu G; Ma L; Xu P; Xian B; Wu L; Ding J; He X; Xia H; Ding W; Yang Z; Peng Q
    Front Genet; 2022; 13():840577. PubMed ID: 35432459
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel truncating variant of MN1 penultimate exon identified in a Chinese patient with newly recognized MN1 C-terminal truncation syndrome: Case report and literature review.
    Zhao A; Shu D; Zhang D; Yang B; Hong L; Wang A; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Gu Q
    Int J Dev Neurosci; 2022 Feb; 82(1):96-103. PubMed ID: 34708882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features.
    Fukuda T; Hiraide T; Yamoto K; Nakashima M; Kawai T; Yanagi K; Ogata T; Saitsu H
    Eur J Med Genet; 2020 Apr; 63(4):103804. PubMed ID: 31698099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.